Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76


Meis1 regulates proliferation of non-small-cell lung cancer cells.

Li W, Huang K, Guo H, Cui G.

J Thorac Dis. 2014 Jun;6(6):850-5. doi: 10.3978/j.issn.2072-1439.2014.06.03.


Inhibition of non-small-cell lung cancer cell proliferation by Pbx1.

Li W, Huang K, Guo H, Cui G, Zhao S.

Chin J Cancer Res. 2014 Oct;26(5):573-8. doi: 10.3978/j.issn.1000-9604.2014.08.21.


Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells.

Ling DJ, Chen ZS, Liao QD, Feng JX, Zhang XY, Yin TY.

Exp Ther Med. 2016 Aug;12(2):1225-1231. Epub 2016 May 24.


meis1 regulates cyclin D1 and c-myc expression, and controls the proliferation of the multipotent cells in the early developing zebrafish eye.

Bessa J, Tavares MJ, Santos J, Kikuta H, Laplante M, Becker TS, Gómez-Skarmeta JL, Casares F.

Development. 2008 Mar;135(5):799-803. doi: 10.1242/dev.011932. Epub 2008 Jan 23.


MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ.

J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35.


Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells.

Illiano M, Nigro E, Sapio L, Caiafa I, Spina A, Scudiero O, Bianco A, Esposito S, Mazzeo F, Pedone PV, Daniele A, Naviglio S.

Pulm Pharmacol Ther. 2017 Aug;45:114-120. doi: 10.1016/j.pupt.2017.05.009. Epub 2017 May 12.


Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells.

Wu F, Zhou L, Jin W, Yang W, Wang Y, Yan B, Du W, Zhang Q, Zhang L, Guo Y, Zhang J, Shan L, Efferth T.

Front Pharmacol. 2016 Dec 2;7:465. eCollection 2016.


Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation.

Ay AS, Benzerdjeb N, Sevestre H, Ahidouch A, Ouadid-Ahidouch H.

PLoS One. 2013 Sep 13;8(9):e72889. doi: 10.1371/journal.pone.0072889. eCollection 2013. Erratum in: PLoS One. 2015;10(4):e0124201. Benzerdjerb, Nazim [corrected to Benzerdjeb, Nazim].


A role for MEIS1 in MLL-fusion gene leukemia.

Kumar AR, Li Q, Hudson WA, Chen W, Sam T, Yao Q, Lund EA, Wu B, Kowal BJ, Kersey JH.

Blood. 2009 Feb 19;113(8):1756-8. doi: 10.1182/blood-2008-06-163287. Epub 2008 Dec 24.


MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.

Rosales-Aviña JA, Torres-Flores J, Aguilar-Lemarroy A, Gurrola-Díaz C, Hernández-Flores G, Ortiz-Lazareno PC, Lerma-Díaz JM, de Celis R, González-Ramella Ó, Barrera-Chaires E, Bravo-Cuellar A, Jave-Suárez LF.

J Exp Clin Cancer Res. 2011 Dec 20;30:112. doi: 10.1186/1756-9966-30-112.


The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV.

Cancer Res. 2006 Feb 15;66(4):2153-61.


Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells, and Cancer.

Aksoz M, Turan RD, Albayrak E, Kocabas F.

Curr Drug Targets. 2017 Jul 24. doi: 10.2174/1389450118666170724165514. [Epub ahead of print]


NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.

Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, Chunlei G, Zhangchao L, Yuanbo X, Jinyan Y, Gaofeng L, Xin S.

J Hematol Oncol. 2015 Oct 26;8:120. doi: 10.1186/s13045-015-0203-8. Erratum in: J Hematol Oncol. 2016;9:11.


MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.

Zhong K, Chen K, Han L, Li B.

BMC Cancer. 2014 Sep 24;14:703. doi: 10.1186/1471-2407-14-703.


Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.

Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6929-35. eCollection 2014.


RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy.

Voruganti S, Xu F, Qin JJ, Guo Y, Sarkar S, Gao M, Zheng Z, Wang MH, Zhou J, Qian B, Zhang R, Wang W.

Cancer Lett. 2015 Dec 28;369(2):386-95. doi: 10.1016/j.canlet.2015.09.003. Epub 2015 Sep 21.


Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.

El-Awady RA, Hersi F, Al-Tunaiji H, Saleh EM, Abdel-Wahab AH, Al Homssi A, Suhail M, El-Serafi A, Al-Tel T.

Cancer Biol Ther. 2015;16(7):1056-70. doi: 10.1080/15384047.2015.1046023.


In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells.

Zimonjic DB, Chan LN, Tripathi V, Lu J, Kwon O, Popescu NC, Lowy DR, Tamanoi F.

BMC Cancer. 2013 Apr 22;13:198. doi: 10.1186/1471-2407-13-198.


Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.

Du J, Zhang L.

Oncol Rep. 2015 Aug;34(2):585-94. doi: 10.3892/or.2015.4023. Epub 2015 May 29.


Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.

Dhar SS, Alam H, Li N, Wagner KW, Chung J, Ahn YW, Lee MG.

J Biol Chem. 2014 Mar 14;289(11):7483-96. doi: 10.1074/jbc.M113.521625. Epub 2014 Jan 30.

Supplemental Content

Support Center